Literature DB >> 6204001

Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.

A N Houghton, T M Thomson, D Gross, H F Oettgen, L J Old.   

Abstract

IFN-gamma is known to induce expression of Ia antigens on a variety of cell types. In the present study, this activity of IFN-gamma has been analyzed with a panel of 36 melanoma cell lines, normal melanocytes, and 97 cell lines representing a range of other differentiation lineages. 55% of the melanoma cell lines express Ia antigens in a constitutive manner without IFN-gamma induction. Of the 16 Ia-melanoma lines, 13 could be induced to express Ia antigens by IFN-gamma, whereas three were noninducible. Melanocytes, which do not normally express Ia antigens, are converted to Ia expression by IFN-gamma. Ia antigens expressed constitutively or after IFN-gamma induction were identified with antibodies detecting monomorphic and allomorphic products of DR and DC loci. IFN-gamma appeared to be unique in its ability to induce Ia expression on melanoma and melanocytes; 14 other agents (including IFN-alpha and IFN-beta) known to influence growth or differentiation did not have Ia-inducing activity. Equally striking is the restriction of antigenic changes following IFN-gamma induction to HLA-associated products; of the 38 systems of cell surface antigens examined, only HLA-A,B,C, beta 2m, and Ia antigens were affected. A variety of other Ia- cell types were shown to be Ia-inducible by IFN-gamma; these included established lines of breast, colon, pancreas, bladder, kidney, ovary, and brain cancers, and cultures of normal fibroblasts, kidney epithelia, and epidermal keratinocytes. In contrast, three tumor types, teratocarcinoma, choriocarcinoma, and neuroblastoma, were not inducible for Ia expression, even though IFN-gamma could induce expression of HLA-A,B,C products. The broad representation of Ia antigens on most somatic cell types expressed either constitutively or after IFN-gamma can be viewed in an immunological context (antigen presentation/immune regulatory signals) or could indicate that Ia products have functions other than those related to immune reactions.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6204001      PMCID: PMC2187416          DOI: 10.1084/jem.160.1.255

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  32 in total

1.  Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon.

Authors:  J S Pober; T Collins; M A Gimbrone; R S Cotran; J D Gitlin; W Fiers; C Clayberger; A M Krensky; S J Burakoff; C S Reiss
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

2.  The distribution of DR5, MT2, and MB3 specificities on human Ia subsets.

Authors:  N Tanigaki; R Tosi; K Sagawa; J Minowada; G B Ferrara
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

3.  The distribution, ontogeny and origin in the rat of Ia-positive cells with dendritic morphology and of Ia antigen in epithelia, with special reference to the intestine.

Authors:  G Mayrhofer; C W Pugh; A N Barclay
Journal:  Eur J Immunol       Date:  1983-02       Impact factor: 5.532

4.  Interferon-gamma induces enhanced expression of Ia and H-2 antigens on B lymphoid, macrophage, and myeloid cell lines.

Authors:  G H Wong; I Clark-Lewis; L McKimm-Breschkin; A W Harris; J W Schrader
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

5.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

6.  Differential regulation of HLA-DR mRNAs and cell surface antigens by interferon.

Authors:  F Rosa; D Hatat; A Abadie; D Wallach; M Revel; M Fellous
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

7.  Three Ia species with different structures and alloantigenic determinants in an HLA-homozygous cell line.

Authors:  N Tanigaki; R Tosi; R J Duquesnoy; G B Ferrara
Journal:  J Exp Med       Date:  1983-01-01       Impact factor: 14.307

8.  Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon.

Authors:  J S Pober; M A Gimbrone; R S Cotran; C S Reiss; S J Burakoff; W Fiers; K A Ault
Journal:  J Exp Med       Date:  1983-04-01       Impact factor: 14.307

9.  Ia antigens in rat kidney, with special reference to their expression in tubular epithelium.

Authors:  G Mayrhofer; M A Schon-Hegrad
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

10.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets.

Authors:  A N Houghton; M Eisinger; A P Albino; J G Cairncross; L J Old
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

View more
  54 in total

1.  Multiple HLA class II-restricted melanocyte differentiation antigens are recognized by tumor-infiltrating lymphocytes from a patient with melanoma.

Authors:  Paul F Robbins; Mona El-Gamil; Yong F Li; Gang Zeng; Mark Dudley; Steven A Rosenberg
Journal:  J Immunol       Date:  2002-11-15       Impact factor: 5.422

2.  Expression of alternatively spliced HLA class II transcripts in lymphoid and nonlymphoid tissues.

Authors:  C Seidl; J S Lee
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Antigen expression of metastasizing and non-metastasizing human melanoma cells xenografted into nude mice.

Authors:  G N Van Muijen; L M Cornelissen; C F Jansen; C G Figdor; J P Johnson; E B Bröcker; D J Ruiter
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

4.  Human cervical epithelial cells that express HLA-DR associated with viral infection and activated mononuclear cell infiltrate.

Authors:  S Fais; F Delle Fratte; F Mancini; V Cioni; M Guadagno; G Vetrano; F Pallone
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

5.  Induction of HLA-DR antigen expression in human endometrial epithelial cells in vitro by recombinant gamma-interferon.

Authors:  S S Tabibzadeh; M A Gerber; P G Satyaswaroop
Journal:  Am J Pathol       Date:  1986-10       Impact factor: 4.307

6.  Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.

Authors:  Junko Matsuzaki; Takemasa Tsuji; Immanuel Luescher; Lloyd J Old; Protul Shrikant; Sacha Gnjatic; Kunle Odunsi
Journal:  Cancer Immunol Res       Date:  2013-12-17       Impact factor: 11.151

Review 7.  Genetics of HLA class II regulation.

Authors:  C R Hume; J S Lee
Journal:  Immunol Res       Date:  1990       Impact factor: 2.829

Review 8.  Interferon-alpha in malignant and viral diseases. A review.

Authors:  R T Dorr
Journal:  Drugs       Date:  1993-02       Impact factor: 9.546

9.  Enhanced serum levels of soluble HLA class I molecules are induced by treatment with recombinant interferon-gamma (IFN-gamma).

Authors:  W E Aulitzky; H Grosse-Wilde; U Westhoff; H Tilg; W Aulitzky; G Gastl; M Herold; C Huber
Journal:  Clin Exp Immunol       Date:  1991-11       Impact factor: 4.330

10.  Expression of HLA antigens in paraffin sections of uveal melanomas.

Authors:  M J Jager; D de Wolff-Rouendaal; A C Breebaart; D J Ruiter
Journal:  Doc Ophthalmol       Date:  1986-12-30       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.